BITETTO, Davide
 Distribuzione geografica
Continente #
NA - Nord America 1.335
EU - Europa 298
AS - Asia 140
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.777
Nazione #
US - Stati Uniti d'America 1.327
UA - Ucraina 84
CN - Cina 54
DE - Germania 53
SG - Singapore 49
SE - Svezia 45
IT - Italia 35
IE - Irlanda 21
GB - Regno Unito 18
TR - Turchia 16
FR - Francia 15
IR - Iran 13
FI - Finlandia 10
BE - Belgio 8
CA - Canada 7
VN - Vietnam 5
IN - India 3
PL - Polonia 2
RU - Federazione Russa 2
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ES - Italia 1
EU - Europa 1
NO - Norvegia 1
TG - Togo 1
ZA - Sudafrica 1
Totale 1.777
Città #
Fairfield 188
Chandler 186
Woodbridge 123
Seattle 76
Houston 75
Ashburn 67
Ann Arbor 65
Wilmington 62
Jacksonville 54
Cambridge 53
Dearborn 45
Singapore 45
Boardman 31
Princeton 22
Dublin 21
Beijing 19
Udine 17
Izmir 14
San Diego 14
Leawood 11
Los Angeles 11
Munich 11
Falls Church 9
Brussels 8
Trieste 8
Zanjan 8
Norwalk 7
Des Moines 5
Dong Ket 5
Kunming 5
Dallas 4
Fuzhou 4
Ottawa 4
Ardabil 3
Augusta 3
Nanjing 3
Ogden 3
San Mateo 3
Zhengzhou 3
Acworth 2
Guangzhou 2
Henderson 2
Huzhou 2
Monmouth Junction 2
New York 2
Padova 2
Toronto 2
Warsaw 2
Washington 2
Wuhan 2
Andover 1
Bassano Del Grappa 1
Castenedolo 1
Chengdu 1
Chongqing 1
Delhi 1
Edinburgh 1
Grafing 1
Hefei 1
Hengyang 1
Jiaxing 1
Liuzhou 1
Lomé 1
Lyon 1
Nanchang 1
Nanning 1
Oslo 1
Pamplona 1
Paris 1
Phoenix 1
Prague 1
Santa Clara 1
Vancouver 1
Vienna 1
Zurich 1
Totale 1.342
Nome #
Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. 183
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. 140
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. 123
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. 120
Biliary strictures after liver transplantation: Role of interleukin 28B genotypes in cyclosporine treated 114
Clinical and virologic response to entecavir in HBV related chronic hepatitis or cirrhosis: data from the clinical practice in a single centre cohort. 110
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E e4 carriers: relationship with the blood lipid profile 106
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 101
GENE POLYMORPHISM AT THE INTERLEUKIN 6 -174 G > C LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 101
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. 96
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. 96
INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME I/D GENE POLYMORPHISM ON CLINICAL AND HISTOLOGICAL CORRELATES OF CHRONIC HEPATITIS C 96
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. 96
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 85
Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis 44
Challenges and future developments in liver transplantation 38
Recurrent and treatment-unresponsive spontaneous bacterial peritonitis worsens survival in decompensated liver cirrhosis 36
New organ allocation criteria in liver transplantation 31
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency 29
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 24
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study 24
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: Implications for clinical management 23
Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients 17
Totale 1.833
Categoria #
all - tutte 7.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020341 0 0 0 0 44 72 64 53 40 38 3 27
2020/2021329 5 27 37 55 10 33 15 27 30 14 53 23
2021/2022204 8 11 14 12 3 10 14 3 9 24 71 25
2022/2023336 27 47 1 61 29 81 0 22 54 2 5 7
2023/202474 16 10 14 0 7 10 0 2 4 11 0 0
2024/2025110 5 29 17 37 22 0 0 0 0 0 0 0
Totale 1.833